Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes

INTRODUCTION

Coronary artery disease (CAD) and dementia are two of the leading causes of death and disability worldwide, accounting for an estimated annual burden of 9 million and 2 million deaths, respectively (1,2). While both conditions occur as the result of separate and complex disease processes arising from diverse aetiologies, accumulating evidence suggests that each may share common – and at times potentially modifiable – underlying risk factors that act to simultaneously increase the risk of both diseases.

The most common cause of dementia is Alzheimer’s Disease (AD), responsible for 60-70% of dementia diagnoses (3). AD is characterized by a progressive decline in memory and thinking skills that are believed to arise from an accumulation of amyloid plaques and neurofibrillary tau tangles in the brain that are the hallmark of a diagnosis. Recent years have seen a wealth of research investigating the role that genetic variants play in the development of AD (4–6), and how this risk may be attenuated by the adoption of healthy lifestyle behaviours at a younger age (7–10).

Cerebrovascular disease also contributes to a significant proportion of dementia diagnoses, however, both in the form of overt vascular dementia and as a co-pathology present in an estimated 50-80% of Alzheimer’s diagnoses (11–13) As atherosclerosis-related hypoperfusion plays a major role in both CAD and cerebrovascular disease (14,15), an underlying genetic predisposition to atherosclerosis may therefore represent an important link in the relationship between heart and brain health. In support of this, polygenic risk scores (PRS) for atherosclerotic CAD have previously been linked to both reduced cognitive function (16) and brain atrophy (17) in later life, implying that shared genetic pathways underlying CAD may also increase risk of future dementia. No study to-date has directly tested this relationship over long-term follow-up or investigated the impact that healthy lifestyle behaviours earlier in the lifespan may have on different dementia outcomes.

Utilising data from a large-scale cohort study of over 360,000 participants prospectively followed for 14 years, our primary aims were to 1) assess whether a PRS for CAD was associated with an increased risk of developing three common dementia subtypes (all-cause, Alzheimer’s Disease, and vascular) during the transition through mid-to-late life, and 2) assess whether this risk was attenuated in those following healthy lifestyle behaviours at their baseline assessment. A secondary aim was to assess underlying changes in brain structure that may explain these differences in risk in a subset of over 35,000 individuals recalled for MRI neuroimaging.

METHODS

RESULTS

Sample Characteristics

The final study sample consisted of 365,782 individuals, 8,870 of whom had all-cause dementia during a median follow-up of 13.9 years (Supplemental Figure 1). Both PRS and LRS were normally distributed (Figure 1). Participants with dementia were on average older than participants without dementia. A greater proportion of participants with Alzheimer’s disease were female, while participants with vascular dementia were more likely to be male. Full baseline characteristics are presented in Table 2 and details on data missingness can be found in Supplemental Table 1.

• Download figure
• Open in new tab

Figure 1: Distribution of Polygenic and Lifestyle Risk Scores for Coronary Artery Disease

PRS, polygenic risk score; LRS, lifestyle risk score.

• Download figure
• Open in new tab

Figure 2: Forest Plots Showing Hazard Ratios for Combined Genetic and Lifestyle Risk for Coronary Artery Disease and Incident Dementia Subtypes

Cox regression models adjusting for age, sex, highest education level, and socioeconomic status. Data expressed as hazard ratios and 95% confidence intervals compared to reference category of combined low genetic and lifestyle risk. Low, mid, and high categories of genetic and lifestyle risk refer to tertiles of PRS and LRS, respectively. HR, hazard ratio.

• Download figure
• Open in new tab

Figure 3: Forest Plots Showing Hazard Ratios for Combined Genetic and Lifestyle Risk for Coronary Artery Disease and Neuroimaging Phenotypes

Multivariable regression models adjusting for age, sex, highest education level, socioeconomic status, total brain volume (not WMH), and childhood body size. Data expressed as % difference in geometric mean and 95% confidence intervals compared to reference category of combined low genetic and lifestyle risk. Low, mid, and high categories of genetic and lifestyle risk refer to tertiles of PRS and LRS, respectively. HR, hazard ratio.

View this table:

• View inline
• View popup
• Download powerpoint

Table 2: Participant Characteristics

Data represent mean ± SD, median (IQR), or n (%). BMI, body mass index; BP, blood pressure; HbA1, glycated haemoglobin; LDL-C, low-density lipoprotein cholesterol.

DISCUSSION

In this large UK-based longitudinal population study followed for up to 14 years, we provide four novel and important findings linking heart and brain health. First, we show that individuals who are genetically predisposed to developing coronary artery disease also face an increased risk of developing dementia in later-life. Second, we demonstrate that this risk is reduced in those maintaining good cardiovascular health in the years preceding diagnosis, regardless of underlying genetic predisposition. Third, we show that this lifestyle-related risk reduction appears to be driven almost solely by a reduced incidence of vascular dementia cases, rather than through any association with Alzheimer’s disease. Finally, in a sub-set of individuals free from dementia at time of assessment, we provide evidence for early signs of vascular damage (i.e. white matter hyperintensity burden) that broadly mirror patterns observed for progression to vascular dementia.

While associations between genetic variation and dementia risk have been extensively studied in recent years, these have almost exclusively been for Alzheimer’s disease – the most common underlying cause of dementia (7,8,34). To the best of our knowledge, no study to-date has addressed the impact that a genetic predisposition to atherosclerotic vascular disease may also have on future dementia risk. Given well-established links in the literature between heart and brain health (35), alongside prior evidence for reductions in cognitive (16) and brain reserve (17) in individuals at high genetic risk for coronary heart disease, we hypothesized that genetic variants associated with an increased risk for CAD may also increase the risk of dementia in those surviving to old age. Our findings support this hypothesis, demonstrating a ∼20% increased risk of all-cause dementia when comparing individuals in the top vs bottom tertile for a genome-wide CAD PRS. By utilizing the statistical power afforded by the large number of incident dementia cases available in UK Biobank to separate these diagnoses into Alzheimer’s and vascular dementia cases, we found that this observed increase in risk was roughly double that for individuals diagnosed with the less common form of vascular dementia (∼32%) compared to Alzheimer’s disease (∼17%). Together, these findings suggest that shared genetic factors may underlie the development of both coronary artery disease and dementia cases that possess an underlying vascular pathology, perhaps through joint detrimental effects on the vasculature that impact perfusion within both the heart and brain.

Given that an individual’s genotype is fixed at conception, the question of whether this increased genetic risk is deterministic – or is instead mediated through other downstream pathways potentially amenable to modification – is an important consideration for population health and prevention strategies. It is now well-established that much of the genetic risk for CAD can be offset through the adoption of healthy lifestyle behaviours (36–38), and recent years have seen an increased focus on whether the same may be true for dementia (7,8,34). This interest has been spurred on in large part by the 2020 Lancet Commission Report on Dementia, in which it has been estimated that up to 40% of all dementias may be preventable by addressing twelve potentially modifiable risk factors with well-established links to heart disease (39). In support of these claims, we found that risk for incident all-cause dementia over 14 years of follow-up was lower in those with better cardiovascular health scores at their baseline assessment, regardless of underlying genetic risk. Furthermore, this reduction appeared to be driven almost exclusively through a reduced incidence of vascular dementia diagnoses, as well as being broadly mirrored by the magnitude of white matter hyperintensity burden measured in a subset of participants undergoing neuroimaging assessments. Together, these findings have several potentially important implications. First, with the heritability of Alzheimer’s disease predicted to be in the range of 70-80% (40), opportunities to modify AD-related pathologies such as amyloid and tau accumulation may be challenging except through pharmacological means. Our findings instead support a role for improved vascular health as one of the key targets for future dementia prevention strategies. Indeed, the improved management of cardiovascular disease in recent decades is hypothesized to provide the most likely explanation for the unexpected reductions in age-standardized dementia rates that have recently been observed in the developed world (41). It should be noted that these improvements are commonly believed to occur not only through a reduction in overt vascular dementia cases, but by also increasing the resilience of the brain to the negative effects of AD-specific pathologies encountered in Alzheimer’s disease (42). While we saw evidence here of the former, we did not observe any evidence for a protective association between cardiovascular health and incidence of Alzheimer’s disease – findings which contrast with other studies from this cohort (7,34). Reasons for these discrepancies are unclear but may involve the choice of the LE8 cardiovascular health score as our exposure, a composite score which contains a range of both behavioral and biological risk factors which may not all be specific or relevant to Alzheimer’s disease. Second, when assessing underlying neuroimaging phenotypes in a subset of the cohort recalled for MRI brain imaging, we observed significantly higher volumes of white matter hyperintensities (a well-established marker of vascular damage) in individuals at increased genetic and lifestyle risk for CAD. These associations appeared to be additive, such that those at high risk for CAD through both genes and lifestyle were found to have WMH volumes ∼30% higher than those at low risk. In contrast, cortical grey matter volumes and hippocampal volumes – two imaging metrics with well-established links to Alzheimer’s disease – showed no association with our CAD PRS and demonstrated only negligible associations with our lifestyle risk score. These findings again suggest that the biological pathways underlying the observed associations in this study are likely to at least in part differ from those commonly studied in relation to Alzheimer’s disease, and instead may act through pathways predominantly compromising the cerebrovasculature.

Future work is required to investigate these biological pathways and to determine how they link genetic risk for CAD to late-life dementia incidence. Recent work using Mendelian Randomization techniques to investigate a potential causal connection between these diseases has found little evidence connecting manifest CAD to brain health (43), suggesting that overt ischemic heart disease per se is unlikely to be the direct causal mechanism influencing dementia risk. The use of a genome-wide PRS in the current study instead suggests that both CAD and vascular dementia may instead possess a shared underlying genetic architecture that simultaneously increases risk of both diseases. This risk could manifest through the downstream mediation of established biological risk factors lying on the causal pathway between genes and both diseases (i.e. vertical pleiotropy), as has been suggested in one recent study for blood pressure (44). Alternatively, associations could represent evidence of gene-environment correlations (where genes influence an individual’s exposure to adverse social environments that themselves influence risk), or horizontal pleiotropy (where CAD genes influence dementia risk through other traits independent of CAD per se). Regardless of the underlying mechanisms, however, our findings demonstrate that genetic risk for CAD also increases risk of vascular dementia, particularly in those who do not adhere to well-established cardiovascular health guidelines earlier in their lifecourse.

This study has a number of limitations. First, participants reporting non-White ancestry were excluded to minimise residual confounding due to population stratification. Future studies addressing this research question in diverse ancestries are therefore warranted. Second, information about some lifestyle factors were obtained by self-report and biases may inevitably occur, as opposed to obtaining objective data where possible. Third, healthy lifestyle factors were not randomly assigned, unlike genetic makeup. Thus, despite efforts to adjust for a number of potentially confounding factors, it is possible that genetics or other external factors were responsible for the relationship between lifestyle risk and dementia. Finally, dementia diagnoses were obtained from electronic health records, which in validation studies have been shown to have a lower positive predictive value for vascular dementia compared to all-cause dementia and Alzheimer’s disease (21).

In conclusion, in this large prospective UK population-based cohort, we provide evidence for an association between an elevated genetic risk for coronary artery disease and an increased risk of dementia. Importantly, this risk was reduced in individuals maintaining optimal cardiovascular health in the years preceding diagnosis, predominantly through reductions in incident vascular dementia. Overall, our findings indicate that, regardless of underlying genetic risk for CAD, lifestyle modifications targeting cardiovascular risk may also lower risk of dementia in older age, especially in diagnoses with an underlying vascular component.

SOURCES OF FUNDING

VG is supported by a Diabetes Research and Wellness Foundation Professor David Matthews Non-Clinical Fellowship (SCA/01/NCF/22). STC is supported by an Alzheimer’s Research UK David Carr Fellowship (ARUK-RF2021B-006).

DISCLOSURES

None.